판매 및 관리 비용 변화 날짜
AstraZeneca USD 5.06B 455M 2026-03
Bayer EUR 3.7B 356M 2026-03
Essilor EUR 5.62B 4.53B 2025-12
Fresenius EUR 819M 143M 2025-12
Fresenius Medical Care EUR 749M 36M 2026-03
GlaxoSmithKline GBP 2.12B 558M 2026-03
GRIFOLS EUR 281M 5.7M 2026-03
Merck EUR 1.52B 80M 2026-03
Novartis USD 3.14B 296M 2026-03
Philips EUR 1.18B 121M 2026-03
Roche Holding CHF 7.28B 3.99B 2025-12
Sanofi EUR 2.33B 419M 2026-03
Smith & Nephew USD 1.42B 65M 2025-12
Sonova Holding CHF 880.2M 300K 2025-06
UCB EUR 1.47B 193M 2025-12